Related Topics
Raleigh, N.C. — Salix Pharmaceuticals is seeking Food and Drug Administration approval for a new dosage of its ulcerative colitis drug Colazal.
Salix said Tuesday it had filed a new drug application with the FDA seeking a 1100 milligram tablet in addition to the currently available 750 mg. The larger dosage would permit twice-a-day dosage, the company said.
The FDA could review the application in 10 months, Salix said.
Related Items
On The Web
![[search]](http://wwwcache.wral.com/presentation/v1/images/icons/16x12/search-form-icon.gif)
Site Search
Salix Seeks OK for New Dosage of Colitis Drug
Copyright 2007 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
News Alerts to your Email & Cell Phone-
- Argos Therapeutics wraps up remainder of $35.2M in financing
Updated at 3:06 p.m. - Internet Summit - Lots of highs, a few lows
Updated at 1:19 p.m. - N.C. adds jobs but unemployment rate reaches 7%
Updated 51 minutes ago - Duke cardiologist could be next head of FDA
Posted at 7:50 a.m. - Future shock? A more dangerous world looms, warns new report
Updated at 8:51 a.m.
- Argos Therapeutics wraps up remainder of $35.2M in financing
-
- What do entrepreneurs do now?
Nov. 20, 2008 - Internet Summit consensus: SaaS is hot!
Nov. 20, 2008 - Atlanta chip startup VT Silicon lands $5.5M in financing
Nov. 20, 2008 - Quit building mansions and focus on execution, Lulu’s Bob Young says
Nov. 20, 2008 - Interact911 closes on $28M in new financing
Nov. 20, 2008
- What do entrepreneurs do now?
More from wrallocaltechwire.com
Market Watch
